SpeechPathology.com Phone: 800-242-5183


Every Special Child - July 2024

VitalStim Therapy with Pacemakers

Yorick Wijting Pt

February 23, 2009

Share:

Question

Is VitalStim therapy contraindicated in patients who have electronic devices such as pacemakers or internal defibrillators?

Answer

During VitalStim Therapy a low amplitude current passes through surface electrodes to the swallowing muscles in the anterior neck. This kind of muscle stimulation is typically referred to as Neuromuscular Electrical Stimulation (NMES). The FDA normally considers implanted electronic devices a contraindication for the use of NMES but in the case of VitalStim Therapy this is not the case because of the low amplitude used. An implanted electronic device such as a pacemaker is still labeled as a precaution to the use of VitalStim Therapy, which means that the therapist must observe the patient for any signs of electromagnetic interference (EMI) between the implanted and the external device. If EMI occurs the treatment should be discontinued and the referring physician should be contacted. Such occurrences are however very unlikely and have to date not been reported.

Yorick Wijting, PT, DPT. Yorick received his degree in Physical Therapy in the Netherlands. He has practiced physical therapy in various care settings across Europe, South Africa and the United States. He has extensive training and practical experience in electrotherapy and teaches nationally and internationally to medical professionals on its therapeutic use. Yorick has been instrumental in promoting and developing the use of electrical stimulation by Speech Language Pathologists in the treatment of dysphagia (VitalStim Therapy). Yorick currently lives in California and works with Empi Recovery Sciences as the Director of Clinical and Market Development, focusing primarily on VitalStim Therapy. In this role he promotes research initiatives, facilitates educational programs and assists in the development of new methodologies and applications for electrotherapy.


yorick wijting pt

Yorick Wijting Pt


Related Courses

Thickened Liquids in Clinical Practice: The Plot “Thickens”
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video

Presenter

Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #10497Level: Intermediate1 Hour
  'Working in the healthcare system, thickening liquids are a concern we frequently encounter'   Read Reviews
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'Good factual review of neurodegenerative disease and some therapy solutions'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

20Q: In the Thick of It - The International Dysphagia Diet Standardization Initiative (IDDSI)
Presented by Jennifer Raminick, MA, CCC-SLP, BCS-S, Danielle Ward, MA, CCC-SLP
Text

Presenters

Jennifer Raminick, MA, CCC-SLP, BCS-SDanielle Ward, MA, CCC-SLP
Course: #10756Level: Intermediate1 Hour
  'Quick way to understand why IDDSI was introduced'   Read Reviews
The importance of using IDSSI to provide standardized language when speaking about texture modification is discussed in this course. Comparisons of IDDSI and the National Dysphagia Diet (NDD), as well as IDDSI standards for pediatric vs. adult patients are presented. Additionally, potential barriers, solutions, and frequently asked questions related to implementation of IDDSI are described.

Back to Basics: Swallow Screening: How, When, and Who
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video

Presenter

Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #8969Level: Introductory1 Hour
  'Reviewed swallow screening protocols'   Read Reviews
Screening of swallow function is a well-regarded tool to identify individuals who are potentially at risk of dysphagia and in need of full swallow assessment, but the options are many and varied. This "back to basics" course teaches participants to make informed, evidence-based choices regarding appropriate screening tools specific to their particular patient populations and settings.

ALS: Medications and Oral Care
Presented by Denise Dougherty, MA, SLP
Video

Presenter

Denise Dougherty, MA, SLP
Course: #8717Level: Intermediate1 Hour
  'Great review of best oral hygiene practices and helpful information regarding oral care with ALS population'   Read Reviews
This is Part 1 of a three-part series on amyotrophic lateral sclerosis (ALS). This course will identify medication and complementary alternative medicine that may be used by patients to treat ALS. The importance of saliva management and mouth care as a critical component of their daily care will be discussed, along with strategies. (Part 2: Course #8719, Part 3: #8720)

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.